MedTrace Logo

How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?

NCT05650944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2022-12-14

No results posted yet for this study

Summary

It is aimed to reveal the treatment and prognostic values by evaluating the differences in hematological parameters and indices, especially in dead Covid-19 cases.

Material Method: It is planned to retrospectively examine the hemogram parameters of 125 male, 44 female and 169 critical Covid-19 patients hospitalized between 01.03.2020 and 31.12.2021. Subjects were divided into 2 groups as deceased (77) and living (92) patients according to demographic data such as age and gender.

Statistical evaluation: All analyzes were SPSS 25.0, Kolmogorov Smirnov test was used to determine distribution, median and interquartile range (Tukey's Hinges Percentile) were used to summarize variables. The differences between the Independent-Samples Mann Whitney U Test and the data of the patient groups and the optimal cut-off values, sensitivity and specificity values will be determined by ROC analysis. It will be considered statistically significant when the p value is below 0.05 (with the two-tailed test)

Conditions

Interventions

DIAGNOSTIC_TEST

Hemogram

Sysmex XN-1000 hematological analyzer

Sponsors & Collaborators

  • Hisar Intercontinental Hospital

    lead OTHER

Principal Investigators

  • Ramazan Gozukucuk · Istanbul Galata Universty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-12-31
Completion
2022-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05650944 on ClinicalTrials.gov